Skip to main content
. 2023 Dec 8;15(12):690. doi: 10.3390/toxins15120690

Table 1.

Detection of cleaved Stx2a in STEC infected patients’ sera.

Pt * Sex Age
(y)
Clinical
Symptoms
E. coli
Serogroup
Toxin
Type
RT-PCR
Stx2 Gene
Stx2 by
ELISA
(ng/mL)
Cleaved Stx2 by LCFTS
(ng/mL)
Neutrophil-
Bound Stx2
1 f 1.7 BD, D, H, P, HUS O26 Stx2 + 3.36 2.90 +
2 f 5.6 BD, D, P, HUS O157 Stx2 + 3.37 11.45 +
3 m 8.3 BD, H, P, HUS O127 Stx2 + 2.41 - +
4 f 10.2 BD, D, P O145 Stx2 2.23 1.98 +
5 m 10.2 BD O8 Stx2 + 2.38 -
6 m 3.3 BD, D, P nd Stx2 2.13 -
7 m 6.4 H, P O127 Stx2 + 3.00 8.27 +
8 m 5.7 D, H, P O127 Stx2 + 3.02 - +

* Clinical and microbiological features of 8 STEC-infected patients: sex (3 females and 5 males); age (median 5.7 years, range 1.7–10.2 years); clinical symptoms as bloody diarrhea (BD, 6/8) and/or diarrhea (D, 5/8), hematuria (H, 4/8), proteinuria (P, 7/8), hemolytic uremic syndrome (HUS, 3/8); E. coli serogroup determination; toxin type according to the presence of the gene encoding Stx2 in fecal extracts identified by real time-polymerase chain reaction (RT-PCR) or by direct identification of the toxin type in serum by enzyme-linked immunosorbent assay (ELISA, ng/mL); cleaved Stx2 identified by luminometric cell-free translation system (LCFTS, ng/mL); neutrophil-bound Stx2 (6/8).